SC

Sarah Davenport, CPA

Corporate Controller at Taysha Gene Therapies

Sarah Davenport, CPA has over a decade of work experience and has held various roles in accounting and finance. Sarah'smost recent position was as the Corporate Controller at Taysha Gene Therapies, starting in September 2020. Prior to that, they worked as the Assistant Controller at Hu-Friedy Mfg. Co., LLC from February 2020 to September 2020. From 2019 to 2020, they were the Financial Controller at PharmaCann LLC. From 2018 to 2019, Sarah was the Senior Director of Accounting and Finance at Home Partners of America. Before that, they held positions at AveXis, Inc., where they served as the Director of Accounting from March 2018 to July 2018, and earlier as the Assistant Controller from May 2016 to July 2018. Sarah also worked as an Accounting Manager at Enlivant from July 2015 to May 2016. Sarah has experience as an Accounting Manager and Senior Plant Accountant at Fresenius Kabi USA from 2013 to 2015, and as a Controller/Financial Analyst at Fresenius Kabi from 2011 to 2013. Sarah began their career as an Audit Associate at KPMG from August 2007 to June 2009. Sarah's work experience showcases their expertise in financial control, accounting management, and auditing.

Sarah Davenport, CPA began their education at Northern Illinois University, where they pursued a Bachelor of Science degree in Accountancy from 2004 to 2006. Sarah later went on to complete their Master of Accounting Science from the same university from 2006 to 2007.

Location

Chicago, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Taysha Gene Therapies

Taysha Gene Therapies is on a mission to eradicate severe and life-threatening monogenic CNS disease. With a singular focus on developing curative medicines, they hope to rapidly translate their treatments from bench to bedside.


Industries

Employees

51-200

Links